<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
<Article>
<Journal>
<PublisherName>isfcppharmaspire</PublisherName>
<JournalTitle>Pharmaspire</JournalTitle>
<PISSN>C</PISSN>
<EISSN>o</EISSN>
<Volume-Issue>Volume 11, Issue 4</Volume-Issue>
<PartNumber/>
<IssueTopic>Multidisciplinary</IssueTopic>
<IssueLanguage>English</IssueLanguage>
<Season>October - December, 2019</Season>
<SpecialIssue>N</SpecialIssue>
<SupplementaryIssue>N</SupplementaryIssue>
<IssueOA>Y</IssueOA>
<PubDate>
<Year>2022</Year>
<Month>06</Month>
<Day>14</Day>
</PubDate>
<ArticleType>Pharmaceutics</ArticleType>
<ArticleTitle>A study on chronic hypertension associated cardiac complications (myocardial infarction): parametric analysis</ArticleTitle>
<SubTitle/>
<ArticleLanguage>English</ArticleLanguage>
<ArticleOA>Y</ArticleOA>
<FirstPage>112</FirstPage>
<LastPage>116</LastPage>
<AuthorList>
<Author>
<FirstName>Amanpreet</FirstName>
<LastName>Kaur</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>N</CorrespondingAuthor>
<ORCID/>
<FirstName>Karamjeet</FirstName>
<LastName>Kaur</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Rohit</FirstName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Khadga</FirstName>
<LastName>Raj</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Shamsher</FirstName>
<LastName>Singh</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
</Author>
</AuthorList>
<DOI/>
<Abstract>Background: The present study was aimed to determine hypertension associated to myocardial infarction (MI) as cardiac complication. Materials and Methods: This study was a prospective observational study conducted in private hospital, Jagraon. This study commenced for duration of 6 months from October 2017 to March 2018 as per inclusion and exclusion criteria. Data were collected from patient case sheet, laboratory tests reports, and patient interview into the specially designed data collection form after taking the written consent from patient diagnosed with hypertension and MI. Data analysis was performed using SPSS statistical software. Results: Among 100 study subjects, 63% of patients were male and 37% of patients were female. The mean age of the patients was found to be 68.92 years. The majority of them were from urban area. The common symptoms experienced by the study population were chest pain, perspiration, syncope, dyspnea, nausea, and vomiting. The majority of study population suffered hypertension from 11 to 15 years. Among study population, 65% have MI and 35% study subjects did not have MI. The Pearson correlation between duration of hypertension and myocardial infarction was found to be strong (r = 0.769) and statistically significant (P < 0.01) at 90% confidence interval. Conclusion: This study has found that the prevalence of hypertension induced MI was high in male population as compared to female counterparts and urban are more likely to be affected than people living in rural area. Further the duration of hypertension potentiates MI which suggests that MI may be hypertension induced over a brief period of exposure as comorbidity.</Abstract>
<AbstractLanguage>English</AbstractLanguage>
<Keywords>Clinical profile, heart failure, hypertension, myocardial infarction</Keywords>
<URLs>
<Abstract>https://isfcppharmaspire.com/ubijournal-v1copy/journals/abstract.php?article_id=13841&title=A study on chronic hypertension associated cardiac complications (myocardial infarction): parametric analysis</Abstract>
</URLs>
<References>
<ReferencesarticleTitle>References</ReferencesarticleTitle>
<ReferencesfirstPage>16</ReferencesfirstPage>
<ReferenceslastPage>19</ReferenceslastPage>
<References>1. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke statistics-2017 update: A report from the American Heart Association. Circulation 2017;135:e146-603.
2. Verma N. Introduction to hyperlipidemia and its treatment: A review. Int J Curr Pharm Res 2013;9:6-14.
3. Mendis S. Global Status Report on Noncommunicable Diseases 2014. Geneva: World Health Organization; 2014.
4. Jaralnabi AA, Atawi S, Sagiron WI, Alasmari N, Alasmari H. Effect of education program on nurses’ knowledge, attitudes, and intentions towards myocardial infarction prevention and treatment. Am J Environ Occup Health 2017;2:7-14.
5. Fuchs FD. Blood pressure-lowering drugs: Essential therapy for some patients with normal blood pressure. Expert Rev Cardiovasc Therapy 2004;2:771-5.
6. Rizzoni D, Agabiti-Rosei E. Structural abnormalities of small resistance arteries in essential hypertension. Intern Emerg Med 2012;7:205-12.
7. The Multiple Risk Factor Intervention Trial (MRFIT). A national study of primary prevention of coronary heart disease. JAMA 1976;235:825-7.
8. Ahmed S, Khan A, Ali SI, Saad M, Jawaid H, Islam M, et al. Differences in symptoms and presentation delay times in myocardial infarction patients with and without diabetes: A cross-sectional study in Pakistan. Indian Heart J 2018;70:241-5.
9. Deshmukh S, Deshpande A, Kulkarni ND. Clinical profile of acute myocardial infarction patients from Rural India. Chest 2017;46:92.
10. Sekhri T, Kanwar RS, Wilfred R, Chugh P, Chhillar M, Aggarwal R, et al. Prevalence of risk factors for coronary artery disease in an urban Indian population. BMJ Open 2014;4:e005346.
11. Choudhury KN, Mainuddin AK, Wahiduzzaman M, Islam SM. Serum lipid profile and its association with hypertension in Bangladesh. Vasc Health Risk Manag 2014;10:327.
12. Pandey S, Pandey S, Jhanwar P, Jhanwar A. A prospective study of Myocardial Infarction patients admitted in a tertiary care hospital of South-Eastern Rajasthan. Int J Biol Med Res 2012;3:1694-6.
13. Stallones RA. The association between tobacco smoking and coronary heart disease. Int J Epidemiol 2015;44:735-43.
14. Kaplan RC, Psaty BM, Heckbert SR, Smith NL, Lemaitre RN. Blood pressure level and incidence of myocardial infarction among patients treated for hypertension. Am J Public Health 1999;89:1414-7.
15. Dhadwal JS. Assesment of clinical profile of coronary artery disease in Indian population. Biomed Res 2015;1:117-21.
16. Franklin SS, Wong ND. Hypertension and cardiovascular disease: Contributions of the Framingham heart study. Global Heart 2013;8:49-57.
17. Perticone F, Perticone M, Maio R, Sciacqua A, Andreucci M, Tripepi G, et al. Serum alkaline phosphatase negatively affects endothelium-dependent vasodilation in naand;iuml;ve hypertensive patients novelty and significance. Hypertension 2015;66:874-80.
18. Yusuf S, Hawken S, and;Ocirc;unpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004;364:937-52.
19. Richards AM, Nicholls MG, Troughton RW, Lainchbury JG, Elliott J, Frampton C, et al. Antecedent hypertension and heart failure after myocardial infarction. J Am Coll Cardiol 2002;39:1182-8.</References>
</References>
</Journal>
</Article>
</ArticleSet>